Hantometer / 2026 Live 10 May 2026

Side-by-side comparison

HantavirusCOVID-19
Pathogen familyCoronavirus (SARS-CoV-2)Hantavirus (Hantaviridae)
ReservoirBats; possible intermediate hostWild rodents — species-specific
Person-to-person spreadYes — highly efficient via respiratory droplets and aerosolsAlmost never — only Andes virus in 12% of cases
Incubation period2–14 days1–8 weeks
Hallmark severe symptomPneumonia, ARDS, multi-organ failurePulmonary edema (HPS) or kidney injury + bleeding (HFRS)
Case-fatality ratio< 1% globally (varies by age & wave)HPS: ~36% · HFRS: 0.4–15%
Geographic distributionGlobal pandemicFocal — Asia, Europe, Americas
VaccinesMultiple licensed mRNA, viral-vector and protein vaccinesInactivated vaccines in China & Korea only — none in Americas/Europe
Antiviral treatmentPaxlovid, remdesivir, molnupiravirRibavirin for HFRS only; supportive care for HPS
Pandemic potentialDemonstrated in 2020–2023Low — limited person-to-person spread

Why people compare them

Both diseases produce flu-like prodromes that progress to severe respiratory failure. In the early days of the 2026 hantavirus cruise outbreak, several news outlets ran "could this be the next COVID?" headlines. The short answer is no — hantavirus simply does not spread well between people. The longer answer is that the comparison is useful for explaining what makes each pathogen dangerous in different ways.

Spread — the decisive difference

COVID-19 spreads through the respiratory droplets and aerosols that humans constantly emit while breathing, talking and coughing. Each infected person typically infects two to five others without intervention. Hantavirus does not work this way. Even Andes virus — the only species with documented human-to-human transmission — has a basic reproduction number well below 1, meaning sustained outbreaks die out without intervention.

Severity — hantavirus is more lethal per case

On a per-case basis, hantavirus pulmonary syndrome is far more lethal than COVID-19. Sin Nombre and Andes viruses kill roughly one in three confirmed patients, even with intensive care. COVID-19's case-fatality dropped below 1% as immunity built and treatments improved. The reason hantavirus has not caused a pandemic despite its lethality is precisely because it spreads so poorly.